Stroke is a large, societal problem: one out of four in the Netherlands will get a stroke, with huge consequences for the patient and for society. PP CONTRAST will develop innovative approaches for improving both diagnosis and treatment of patients with a stroke.
PP CONTRAST – Public-Private Collaboration for Novel Technologies for Acute Stroke
In Public-Private CONTRAST (COllaboration for Novel Technologies foR Acute STroke), Erasmus MC, Amsterdam UMC and TU Delft (on behalf of the CONTRAST consortium and Technical Universities) together with private partners will develop innovative approaches for the diagnosis, characterization, and treatment of patients with a stroke, by developing and implementing novel technologies, such as AI and advanced digital twins.
Stroke is a significant societal problem: one out of four in the Netherlands will get a stroke, leading to large societal and healthcare costs. Stroke is the most frequent cause of remaining disability in adults. The well-known phrase “Time is brain” emphasizes the benefit of swift treatment for the patient, the healthcare system, and society: Starting treatment one hour earlier leads to an average reduction of healthcare expenditures of €18,000 per patient.
PP Contrast develops technologies for improving and expediting the diagnosis, such as detection of an intracranial bleeding in the ambulance, and characterizing blood vessel occlusions based on imaging data before treatment. By allowing the improved selection of treatment devices based on patient-specific vessel structures, automated multi-modal analysis of images during the intervention, and patient-specific blood pressure regulation, as well as patient-specific treatment simulation on digital twin platforms, PP CONTRAST contributes to improving treatment of stroke patients resulting in better outcomes.
PP CONTRAST hosts seven pre-selected projects.